KEI comments on the Novartis decision

(James Love / Knowledge Ecology International, 1 April 2013) "The decision is about one important issue for India and other countries, can a WTO member eliminate many of the "evergreening" patents on new medicines, not eliminating patent protection for new drugs, but eliminating all sorts of patents on new delivery mechanisms, doses, and new formulations of older drugs? The answer, by the court, was yes. This is a hugely significant decision, but there will still be battles over patents on new medicines that are not affected by this judgement."

keionline.org